Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Dexmedetomidine × Ethanol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Alcohol Drinking 7 Neoplasms 4 Smoking Cessation 3 Pain 2 Depression 2 Condylomata Acuminata 2 Cardiovascular Diseases 2 Agnosia 2 Wounds and Injuries 1 Warts 1 Visceral Pain 1 Tuberculosis 1 Thyroid Cancer, Papillary 1 Substance-Related Disorders 1 Squamous Cell Carcinoma of Head and Neck 1 Social Isolation 1 Risk-Taking 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Cyst 1 Mouth Neoplasms 1 Lymphoma, Follicular 1 Liver Cirrhosis 1 Infections 1 Head and Neck Neoplasms 1 Flushing 1 Fanconi Anemia 1 Esophageal Neoplasms 1 Epidermodysplasia Verruciformis 1

Interventions

Dexmedetomidine 2 Saline Solution 1 Ethanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05291364 2023-08-01

Dexmedetomidine in Splanchnic Nerve Neurolysis

Minia University

Phase NA Completed

Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡